These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32196549)

  • 1. The killer yeast Wickerhamomyces anomalus Cf20 exerts a broad anti-Candida activity through the production of killer toxins and volatile compounds.
    Fernández de Ullivarri M; Bulacios GA; Navarro SA; Lanza L; Mendoza LM; Chalón MC
    Med Mycol; 2020 Nov; 58(8):1102-1113. PubMed ID: 32196549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel killer toxin produced by the marine-derived yeast Wickerhamomyces anomalus YF07b.
    Guo FJ; Ma Y; Xu HM; Wang XH; Chi ZM
    Antonie Van Leeuwenhoek; 2013 Apr; 103(4):737-46. PubMed ID: 23180377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Candida activity of a novel killer toxin from the yeast Williopsis mrakii.
    Hodgson VJ; Button D; Walker GM
    Microbiology (Reading); 1995 Aug; 141 ( Pt 8)():2003-2012. PubMed ID: 7551063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth inhibition of Candida species by Wickerhamomyces anomalus mycocin and a lactone compound of Aureobasidium pullulans.
    Tay ST; Lim SL; Tan HW
    BMC Complement Altern Med; 2014 Nov; 14():439. PubMed ID: 25380692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of Candida albicans Strains Isolated from Vaginal Secretion in Front of the Mycocins of Wickerhamomyces anomalus.
    Rosseto LRB; Martelli EC; da Silva JC; Nascimento BL; Junges DSB; Delabeneta MF; Paris AP; Auler ME; Menolli RA; Simão RCG; Paula CR; Gandra RF
    Probiotics Antimicrob Proteins; 2022 Jun; 14(3):595-601. PubMed ID: 35451745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candidacidal Activity of a Novel Killer Toxin from Wickerhamomyces anomalus against Fluconazole-Susceptible and -Resistant Strains.
    Giovati L; Santinoli C; Ferrari E; Ciociola T; Martin E; Bandi C; Ricci I; Epis S; Conti S
    Toxins (Basel); 2018 Feb; 10(2):. PubMed ID: 29401638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of a monoclonal killer anti-idiotypic antibody and a synthetic killer peptide against oral isolates of Candida spp. differently susceptible to conventional antifungals.
    Manfredi M; McCullough MJ; Conti S; Polonelli L; Vescovi P; Al-Karaawi ZM; Porter SR
    Oral Microbiol Immunol; 2005 Aug; 20(4):226-32. PubMed ID: 15943767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and susceptibility of clinical isolates of Candida spp. to killer toxins.
    Robledo-Leal E; Rivera-Morales LG; Sangorrín MP; González GM; Ramos-Alfano G; Adame-Rodriguez JM; Alcocer-Gonzalez JM; Arechiga-Carvajal ET; Rodriguez-Padilla C
    Braz J Biol; 2018 Nov; 78(4):742-749. PubMed ID: 29412252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of killer yeasts in isolates of clinical origin.
    Robledo-Leal E; Villarreal-Treviño L; González GM
    Trop Biomed; 2012 Jun; 29(2):297-300. PubMed ID: 22735852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of Candida albicans Isolated from Blood to Wickerhamomyces anomalous Mycocins.
    Paris AP; Persel C; Serafin CF; de Cássia Garcia Simão R; Gandra RF
    Curr Microbiol; 2016 Dec; 73(6):878-884. PubMed ID: 27638312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exoglucanase-encoding genes from three Wickerhamomyces anomalus killer strains isolated from olive brine.
    Muccilli S; Wemhoff S; Restuccia C; Meinhardt F
    Yeast; 2013 Jan; 30(1):33-43. PubMed ID: 23148020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal activity of bio-active cell-free culture extracts and volatile organic compounds (VOCs) synthesised by endophytic fungal isolates of Garden Nasturtium.
    Santra HK; Dutta R; Banerjee D
    Sci Rep; 2024 May; 14(1):11228. PubMed ID: 38755187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postharvest biocontrol ability of killer yeasts against Monilinia fructigena and Monilinia fructicola on stone fruit.
    Grzegorczyk M; Żarowska B; Restuccia C; Cirvilleri G
    Food Microbiol; 2017 Feb; 61():93-101. PubMed ID: 27697174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of two different toxins of Wickerhamomyces anomalus (Pichia anomala) VKM Y-159.
    Farkas Z; Márki-Zay J; Kucsera J; Vágvölgyi C; Golubev WI; Pfeiffer I
    Acta Biol Hung; 2012 Jun; 63(2):277-87. PubMed ID: 22695525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Role of Exoglucanase Genes (WaEXG1 and WaEXG2) in the Biocontrol Activity of Wickerhamomyces anomalus.
    Parafati L; Cirvilleri G; Restuccia C; Wisniewski M
    Microb Ecol; 2017 May; 73(4):876-884. PubMed ID: 27816988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the in vitro antimycotic activity of a novel killer protein from Williopsis saturnus DBVPG 4561 against emerging pathogenic yeasts.
    Buzzini P; Corazzi L; Turchetti B; Buratta M; Martini A
    FEMS Microbiol Lett; 2004 Sep; 238(2):359-65. PubMed ID: 15358421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A yeast strain associated to Anopheles mosquitoes produces a toxin able to kill malaria parasites.
    Valzano M; Cecarini V; Cappelli A; Capone A; Bozic J; Cuccioloni M; Epis S; Petrelli D; Angeletti M; Eleuteri AM; Favia G; Ricci I
    Malar J; 2016 Jan; 15():21. PubMed ID: 26754943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Wickerhamomyces anomalus killer strain in the malaria vector Anopheles stephensi.
    Cappelli A; Ulissi U; Valzano M; Damiani C; Epis S; Gabrielli MG; Conti S; Polonelli L; Bandi C; Favia G; Ricci I
    PLoS One; 2014; 9(5):e95988. PubMed ID: 24788884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance evaluation of volatile organic compounds by antagonistic yeasts immobilized on hydrogel spheres against gray, green and blue postharvest decays.
    Parafati L; Vitale A; Restuccia C; Cirvilleri G
    Food Microbiol; 2017 May; 63():191-198. PubMed ID: 28040168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal activity and expression patterns of extracellular chitinase and β-1,3-glucanase in Wickerhamomyces anomalus EG2 treated with chitin and glucan.
    Hong SH; Song YS; Seo DJ; Kim KY; Jung WJ
    Microb Pathog; 2017 Sep; 110():159-164. PubMed ID: 28668604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.